Genomma Lab Internacional, S.A.B. de C.V. is a Mexico‐based consumer healthcare company founded in 1996. The company specializes in the development, marketing and distribution of self‐care and personal care products. It operates through a diversified portfolio of over‐the‐counter pharmaceuticals, skincare, hair care, adult care and beauty offerings under proprietary brand names. Genomma Lab is publicly listed on the OTC Markets under the ticker GNMLF and maintains its headquarters in Mexico City.
Genomma Lab’s product range includes treatments for acne, pain relief, oral care, dermatological solutions and dietary supplements. Notable brands in its portfolio include Asepxia, Cicatricure, Vitis and Enterogermina. The company places significant emphasis on consumer marketing, leveraging television, digital media and point‐of‐sale programs to drive brand awareness and stimulate demand. Research and development efforts focus on formulation innovation and fast time to market, allowing Genomma Lab to introduce new presentations and line extensions regularly.
The company’s primary markets are Mexico and other countries in Latin America, where it maintains an extensive distribution network spanning pharmacies, supermarkets, convenience stores and e‐commerce platforms. In recent years, Genomma Lab has expanded its presence into the United States—targeting Hispanic channels—and selected European markets such as Spain. Through strategic partnerships and acquisitions, the firm continues to reinforce its position in consumer self‐care and to explore growth opportunities in digital health and wellness segments.
AI Generated. May Contain Errors.
MarketBeat All Access